Jmy, a co-activator for p300/cbp, nucleic acid encoding jmy and uses thereof
CA 2307330 A1 · Owner: The University Court Of The University Of Glasgow · Inventors: Shikama, Noriko; La Thangue, Nicholas Barrie
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides an isolated nucleic acid (SEQ ID No:1) encoding a novel protein, JMY, which is found to be a co-activator of p300/CBP. The invention also provides JMY polypeptides and antibodies thereto as well as assays for , modulators of the cell cycle which target the interaction of JMY with transcription factors such as E2F, ER or TBP.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 21, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 21, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 21, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.